交控科技(688015.SH):中標深圳市城市軌道交通13號線二期(北延)工程、(南延)工程B包信號系統設備採購(合同編號13252)(二次)
格隆匯3月26日丨交控科技(688015.SH)公佈,公司中標項目爲深圳市城市軌道交通13號線二期(北延)工程、(南延)工程B包信號系統設備採購(合同編號13252)(二次),中標金額爲3.02億元。
本次中標項目合同履行期爲合同簽訂日至項目缺陷通知期限結束,深圳市城市軌道交通13號線二期(北延)工程項目暫定於2025年12月開通運營,深圳市城市軌道交通13號線二期(南延)工程項目暫定於2026年6月開通運營,缺陷通知期限2年(以上信息最終以合同簽訂爲準)。雖然公示期已結束,但公司尚未收到此次招標的正式中標通知書,且尚未簽訂相關正式合同,存在不確定性。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.